Valuation: MedPacto, Inc.

Market Cap 105B 78.38M 70.2M 64.57M 58.5M 109M 7.44B 111M 770M 309M 3.91B 294M 288M 12.35B P/E 2024
-7.42x
P/E 2025 -17.9x
Enterprise Value 65.57B 49.16M 44.03M 40.5M 36.69M 68.59M 4.67B 69.87M 483M 194M 2.46B 184M 181M 7.74B EV / Sales 2024
-
EV / Sales 2025 48,733,025x
Free-Float
74%
Yield 2024 *
-
Yield 2025 -
1 day+2.69%
1 week-0.16%
Current month+7.77%
1 month+7.77%
3 months+36.16%
6 months-40.43%
Current year-54.34%
1 week 2,865
Extreme 2865
3,135
1 month 2,705
Extreme 2705
3,600
Current year 2,235
Extreme 2235
7,980
1 year 2,235
Extreme 2235
8,650
3 years 2,235
Extreme 2235
17,240
5 years 2,235
Extreme 2235
69,600
10 years 2,235
Extreme 2235
134,200
Manager TitleAgeSince
Chief Executive Officer 72 19/06/2013
President 66 28/03/2024
Comptroller/Controller/Auditor 70 28/03/2022
Director TitleAgeSince
Director/Board Member 72 19/06/2013
Director/Board Member 66 28/03/2024
Director/Board Member 64 28/03/2024
Date Insider Type Main position Quantity % Market Cap. Importance
4/3/25 Buy 10,000 0.0292%
4/3/25 Buy 10,500 0.0306%
4/3/25 Buy

Chairperson

15,000 0.0438%
Change 5-day change 1-year change 3-year change Capi.($)
+2.69%-0.16%-26.42%-58.84% 75.91M
-0.62%-1.87%+46.31%+56.99% 64.38B
+0.35%+3.20%+14.92%+84.55% 56.16B
+0.53%+1.96%+15.37%+106.81% 54.16B
-2.81%-4.31%+23.50%+50.90% 45.33B
-0.33%-1.93%+20.15%+98.45% 42.25B
+0.55%+2.31%+224.97%+942.56% 40.78B
+3.27%+47.96%+112.67%+96.48% 33.8B
+1.22%-1.44%+14.89%+47.15% 32.25B
+0.89%+20.55%-42.03%+373.03% 24.37B
Average +0.57%+6.23%+40.43%+179.81% 39.36B
Weighted average by Cap. +0.16%+4.83%+48.29%+185.42%

Financials

2024 2025
Net sales - 3.9K 2.92 2.62 2.41 2.18 4.08 277.53 4.15 28.71 11.53 145.99 10.97 10.74 460.39
Net income -20.14B -15.1M -13.52M -12.44M -11.27M -21.07M -1.43B -21.46M -148M -59.55M -754M -56.67M -55.46M -2.38B -12.81B -9.6M -8.6M -7.91M -7.17M -13.4M -912M -13.65M -94.36M -37.88M -480M -36.05M -35.28M -1.51B
Net Debt -53.54B -40.14M -35.95M -33.07M -29.96M -56.01M -3.81B -57.05M -394M -158M -2B -151M -147M -6.32B -38.97B -29.22M -26.17M -24.07M -21.81M -40.77M -2.77B -41.53M -287M -115M -1.46B -110M -107M -4.6B
Projected Income Statement - Annual - MedPacto, Inc.
Logo MedPacto, Inc.
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Employees
56
Date Price Change Volume
30/10/26 KRW 3,050.00 +2.69% 103,226
29/10/26 KRW 2,970.00 +1.54% 92,922
28/10/26 KRW 2,925.00 -2.99% 84,842
27/10/26 KRW 3,015.00 -1.47% 60,988
26/10/26 KRW 3,060.00 +0.16% 71,643
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - MedPacto, Inc.
  1. Stock Market
  2. Stocks
  3. A235980 Stock